The coagulopathy of cirrhosis: Myth or reality?

被引：16

作者：

Bosch, J

Reverter, JC

机构：

[1] Hosp Clin Barcelona, Liver Unit, Hepat Hemodynam Lab, E-08036 Barcelona, Spain

[2] Hosp Clin Barcelona, Hemostasis Lab, Barcelona, Spain

[3] Univ Barcelona, IDIBAPS, Barcelona, Spain

来源：

HEPATOLOGY | 2005年 / 41卷 / 03期

关键词：

D O I：

10.1002/hep.20639

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

引用

页码：434 / 435

页数：2

共 13 条

[1]

[Anonymous], OXFORD TXB CLIN HEPA

[2] Recombinant factor VIIa for upper gastrointestinal bleeding in patients with cirrhosis: A randomized, double-blind trial [J].

Bosch, J ;

Thabut, D ;

Bendtsen, F ;

D'Amico, G ;

Albillos, A ;

Abraldes, JG ;

Fabricius, S ;

Erhardtsen, E ;

De Franchis, R .

GASTROENTEROLOGY, 2004, 127 (04) :1123-1130

[3]

Bosch J, 2003, SCHIFFS DIS LIVER, P429

[4]

BURROUGHS AK, 1991, OXFORD TXB CLIN HEPA, P4408

[5] Deficiency of thrombin activatable fibrinolysis inhibitor in cirrhosis is associated with increased plasma fibrinolysis [J].

Colucci, M ;

Binetti, BM ;

Branca, MG ;

Clerici, C ;

Morelli, A ;

Semeraro, N ;

Gresele, P .

HEPATOLOGY, 2003, 38 (01) :230-237

[6]

FRANCIS RB, 1984, HAEMOSTASIS, V14, P460

[7]

Hedner U, 2003, DIS LIVER, P625

[8] Calibrated automated thrombin generation measurement in clotting plasma [J].

Hemker, HC ;

Giesen, P ;

Al Dieri, R ;

Regnault, V ;

de Smedt, E ;

Wagenvoord, R ;

Lecompte, T ;

Béguin, S .

PATHOPHYSIOLOGY OF HAEMOSTASIS AND THROMBOSIS, 2003, 33 (01) :4-15

[9] A model to predict survival in patients with end-stage liver disease [J].

Kamath, PS ;

Wiesner, RH ;

Malinchoc, M ;

Kremers, W ;

Therneau, TM ;

Kosberg, CL ;

D'Amico, G ;

Dickson, ER ;

Kim, WR .

HEPATOLOGY, 2001, 33 (02) :464-470

[10] Thrombin-activatable fibrinolysis inhibitor deficiency in cirrhosis is not associated with increased plasma fibrinolysis [J].

Lisman, T ;

Leebeek, FWG ;

Mosnier, LO ;

Bouma, BN ;

Meijers, JCM ;

Janssen, HLA ;

Nieuwenhuis, HK ;

De Groot, PG .

GASTROENTEROLOGY, 2001, 121 (01) :131-139

← 1 2 →